TCGX Acquisition (TCGX) Stock Price, News & Analysis
What Changed
- TriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migraine
- The proposed TCGX (TCGX)–TriGemX Bio merger is expected to close in Q1 2027, subject to approvals.
- TriGemX Bio and TCGX Acquisition Corp. Announce Confidential Submission of Draft Registration Statement on Form S-4 in Connection with Proposed Business Combination
Price Move History
- Daily moves over 5%
- 12 65 sessions, August 5, 2026 to November 6, 2026
- Largest daily move
- +21.4% close of August 12, 2026
- 1-month change
- -21.3% closing prices, October 2, 2026 to November 6, 2026
Company Description
TCGX Acquisition (NASDAQ: TCGX) is classified in the shell companies industry within the Financial Services sector and carries a market capitalization of $113.5M.
TCGX has declined 21.3% over the past month. The last closing price was $10.04.
This page collects what Stock Titan holds for TCGX, including price data, latest news, SEC filings, upcoming events, and short interest trends.
Stock Performance
TCGX Acquisition (TCGX) closed at $10.04 on November 6, 2026. Over the past month, the price has lost 21.3%.
TCGX Metrics & Rankings
Price returns through November 6, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
TCGX Acquisition has 4 recent news articles, with the latest published 7 days ago. Of the recent coverage, 1 article coincided with positive price movement and 2 with negative movement. Key topics include acquisition, IPO, offering. View all TCGX news →
SEC Filings
TCGX Acquisition has filed 8 recent SEC filings, including 4 Form 425, 1 Form 8-K, 1 Form 10-Q, 1 Form SCHEDULE 13G. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all TCGX SEC filings →
Financial Highlights
Upcoming Events
Business combination close
Business combination closing
TCGX Acquisition has 2 upcoming scheduled events. The next event, "Business combination close", is expected in Q1 2027. Investors can track these dates to stay informed about potential catalysts that may affect the TCGX stock price.
Short Interest History
Short interest in TCGX Acquisition (TCGX) currently stands at 52.5 thousand shares, down 1.3% from the previous reporting period, representing 0.6% of the float. Since August 2026, short interest has increased by 54.3%.
Days to Cover History
Days to cover for TCGX Acquisition (TCGX) currently stands at 7.4 days, up 152.1% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since August 2026, the figure has increased by 636%. Across the settlements charted above, it has ranged from 1.0 to 7.4 days.
TCGX Company Profile & Sector Positioning
TCGX Acquisition (TCGX) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing TCGX often look at related companies in the same sector, including Pantages Capital Acquisition Corporation (PGAC), Quantumsphere Acquisition Corp. (QUMS), Burtech Acquisition Corp II (BRKH), Plum Acquisition Corp. IV (PLMK), and Rainier Acquisition Corp (RNAQ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate TCGX's relative position within its industry.